Akanda Corp

Akanda Corp

Verified

Launch date
Employees
Market cap
$4.6m
Net debt
($3.9m)
Enterprise valuation
$9m (Public information from Jun 2024)
London England (HQ)
Deals in current and previous year:

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2019202020212022
Revenues0000000000000000
% growth--1909 %6223 %
EBITDA0000000000000000
% EBITDA margin-(68212 %)(15684 %)(626 %)
Profit0000000000000000
% profit margin-(111570 %)(19626 %)(445 %)
EV / revenue00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x
R&D budget0000000000000000
  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

$0.0

round
N/A

$0.0

round
investor

$0.0

round
*
N/A

$2.5m

Post IPO Equity
Total Funding000k

Recent News about Akanda Corp

Edit
More about Akanda Corp
Edit

Akanda Corp is a seed-to-patient supply chain business, connecting patients in the UK and Europe with medical cannabis and wellness products. Akanda's purpose-built indoor grow facility in Portugal is the only one of its kind that can produce EU GMP medical cannabis equivalent to the recreational grades available in North America. They are dedicated to providing high quality and efficacious products to improve quality of life for consumers in legal markets. Akanda also works with leading prescribing doctors, digital pain clinics and distribution partners to bring cannabis-based medicine to international patients. What sets them apart from other businesses in the industry is their ability to produce EU GMP medical cannabis, as well as their dedication to providing high quality and efficacious products to improve quality of life for consumers in legal markets.

Investments by Akanda Corp

Edit
Bophelo
ACQUISITION by Akanda Corp Nov 2021
Canmart
ACQUISITION by Akanda Corp Nov 2021
Holigen
ACQUISITION by Akanda Corp Apr 2022